127 related articles for article (PubMed ID: 29498772)
1. SLAM family member 8 is involved in oncogenic KIT-mediated signalling in human mastocytosis.
Sugimoto A; Kataoka TR; Ueshima C; Takei Y; Kitamura K; Hirata M; Nomura T; Haga H
Exp Dermatol; 2018 Jun; 27(6):641-646. PubMed ID: 29498772
[TBL] [Abstract][Full Text] [Related]
2. SLAM family member 8 is expressed in and enhances the growth of anaplastic large cell lymphoma.
Sugimoto A; Kataoka TR; Ito H; Kitamura K; Saito N; Hirata M; Ueshima C; Takei Y; Moriyoshi K; Otsuka Y; Nishikori M; Takaori-Kondo A; Haga H
Sci Rep; 2020 Feb; 10(1):2505. PubMed ID: 32054954
[TBL] [Abstract][Full Text] [Related]
3. PD-1 regulates the growth of human mastocytosis cells.
Kataoka TR; Fujimoto M; Moriyoshi K; Koyanagi I; Ueshima C; Kono F; Tsuruyama T; Okayama Y; Ra C; Haga H
Allergol Int; 2013 Mar; 62(1):99-104. PubMed ID: 23267208
[TBL] [Abstract][Full Text] [Related]
4. CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells.
Ueshima C; Kataoka TR; Takei Y; Hirata M; Sugimoto A; Hirokawa M; Okayama Y; Blumberg RS; Haga H
Cancer Med; 2017 Apr; 6(4):845-856. PubMed ID: 28332308
[TBL] [Abstract][Full Text] [Related]
5. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
[TBL] [Abstract][Full Text] [Related]
6. CD72 negatively regulates KIT-mediated responses in human mast cells.
Kataoka TR; Kumanogoh A; Bandara G; Metcalfe DD; Gilfillan AM
J Immunol; 2010 Mar; 184(5):2468-75. PubMed ID: 20100931
[TBL] [Abstract][Full Text] [Related]
7. The Killer Cell Ig-like Receptor 2DL4 Expression in Human Mast Cells and Its Potential Role in Breast Cancer Invasion.
Ueshima C; Kataoka TR; Hirata M; Furuhata A; Suzuki E; Toi M; Tsuruyama T; Okayama Y; Haga H
Cancer Immunol Res; 2015 Aug; 3(8):871-80. PubMed ID: 25735953
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1.
Piao X; Paulson R; van der Geer P; Pawson T; Bernstein A
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14665-9. PubMed ID: 8962111
[TBL] [Abstract][Full Text] [Related]
9. Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
Förster A; Grotha SP; Seeger JM; Rabenhorst A; Gehring M; Raap U; Létard S; Dubreuil P; Kashkar H; Walczak H; Roers A; Hartmann K
Allergy; 2015 Jul; 70(7):764-74. PubMed ID: 25833810
[TBL] [Abstract][Full Text] [Related]
10. Combined deficiency of SLAMF8 and SLAMF9 prevents endotoxin-induced liver inflammation by downregulating TLR4 expression on macrophages.
Zeng X; Liu G; Peng W; He J; Cai C; Xiong W; Chen S; Yang M; Dong Z
Cell Mol Immunol; 2020 Feb; 17(2):153-162. PubMed ID: 30552382
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of STAT protein activation by oncogenic KIT mutants in neoplastic mast cells.
Chaix A; Lopez S; Voisset E; Gros L; Dubreuil P; De Sepulveda P
J Biol Chem; 2011 Feb; 286(8):5956-66. PubMed ID: 21135090
[TBL] [Abstract][Full Text] [Related]
12. Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.
Hartmann K; Artuc M; Baldus SE; Zirbes TK; Hermes B; Thiele J; Mekori YA; Henz BM
Am J Pathol; 2003 Sep; 163(3):819-26. PubMed ID: 12937123
[TBL] [Abstract][Full Text] [Related]
13. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT.
Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK
Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925
[TBL] [Abstract][Full Text] [Related]
14. Mast cells in systemic mastocytosis have distinctly brighter CD45 expression by flow cytometry.
Chisholm KM; Merker JD; Gotlib JR; Gitana G; Lefterova M; Zehnder JL; George TI; Arber DA; Ohgami RS
Am J Clin Pathol; 2015 Apr; 143(4):527-34. PubMed ID: 25780004
[TBL] [Abstract][Full Text] [Related]
15. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.
Kalesnikoff J; Rios EJ; Chen CC; Nakae S; Zabel BA; Butcher EC; Tsai M; Tam SY; Galli SJ
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2659-64. PubMed ID: 16533754
[TBL] [Abstract][Full Text] [Related]
16. Molecular changes associated with the development of resistance to imatinib in an imatinib-sensitive canine neoplastic mast cell line carrying a KIT c.1523A>T mutation.
Kobayashi M; Kuroki S; Tanaka Y; Moriya Y; Kozutumi Y; Uehara Y; Ono K; Tamura K; Washizu T; Bonkobara M
Eur J Haematol; 2015 Dec; 95(6):524-31. PubMed ID: 25684098
[TBL] [Abstract][Full Text] [Related]
17. The adaptor 3BP2 is required for KIT receptor expression and human mast cell survival.
Ainsua-Enrich E; Serrano-Candelas E; Álvarez-Errico D; Picado C; Sayós J; Rivera J; Martín M
J Immunol; 2015 May; 194(9):4309-18. PubMed ID: 25810396
[TBL] [Abstract][Full Text] [Related]
18. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2/PTPN11 phosphatase for disease progression in mice.
Sharma N; Everingham S; Zeng LF; Zhang ZY; Kapur R; Craig AW
Oncotarget; 2014 Aug; 5(15):6130-41. PubMed ID: 25026279
[TBL] [Abstract][Full Text] [Related]
20. Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis.
Hartmann K; Hermes B; Rappersberger K; Sepp N; Mekori YA; Henz BM
Br J Dermatol; 2003 Sep; 149(3):554-9. PubMed ID: 14510988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
